RecruitingOpioid Use DisorderMajor Depressive Disorder (MDD)
Helping Kentuckians Overcome Depression and Opioid Addiction With Brain Stimulation
Eligible age
18–75 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study will compare transcranial magnetic stimulation (TMS) with sham TMS in people with opioid use disorder who are taking buprenorphine and have major depressive disorder with ongoing depressive symptoms. The study will evaluate whether TMS improves depressive symptoms and reduces opioid craving. The study will also assess smoking behaviors, treatment acceptability, and any side effects related to TMS.
Sponsor: University of Kentucky
You may qualify if…
- ✓ 18-75 years of age
- ✓ Willing and able to provide informed consent
- ✓ Able to read and speak english
- ✓ Opioid use disorder, in remission for at least a month
- ✓ Diagnosis of major depressive disorder confirmed with the Mini-International Neuropsychiatric Interview (MINI, 7.02)
- ✓ Minimum score of 10 on the 17-item Hamilton Depression Rating Scale (HDRS-17)
- ✓ Opioid craving score of 5 or greater on a 0-10 scale
- ✓ Stabilized on sublingual or depot buprenorphine for at least 8 weeks
You may not qualify if…
- ✕ Seizure disorder
- ✕ any other acute medical or behavioral disorder that would preclude safe participation
- ✕ Pregnant, nursing or planning to become pregnant during the study
- ✕ Magnetic resonance imaging (MRI) contraindications, including ferrous retainers, intracranial implants, or claustrophobia
- ✕ Surgical procedure planned during the study period
- ✕ Any other medical condition that could compromise participant well-being
Where it's recruiting
Kentucky
Lexington
Source: ClinicalTrials.gov · NCT07842601 · last updated 2026-11-17